Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06171412 · ClinicalTrials.gov registry record · NA

Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use

A NA study of Type 1 Diabetes, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
38
Enrollment target
1
Study location

NCT06171412 is a NA study of Type 1 Diabetes that is actively recruiting participants, run by Yale University. The registered enrollment target is 38 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06171412, a NA study of Type 1 Diabetes, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, exercise, and insulin. Use of CGM has been shown to improve health outcomes, but is not used by adolescents of color. Peer mentors may help improve usage.

Conditions Studied

Type 1 Diabetes

Interventions

  • BEHAVIORAL Glu-COACH

Study Locations (1)

Connecticut

  • Yale Children's Diabetes Clinic - New Haven

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2024-05-21
Est. Completion 2027-02
Phase NA

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06171412

The ClinicalTrials.gov registry entry for NCT06171412 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (95% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Glu-COACH is the first listed.

NCT06171412 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06171412 about?

NCT06171412 is a clinical study titled "Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use". This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, ex...

What is the current status of trial NCT06171412?

This trial is currently recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2024-05-21. Estimated completion is 2027-02.

What conditions does trial NCT06171412 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT06171412?

The interventions under investigation include: Glu-COACH (BEHAVIORAL).

Who is sponsoring clinical trial NCT06171412?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06171412 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 1 Diabetes

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.